Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic aberrations are rare in urothelial neoplasms of patients 19 years or younger

27 Oct 2006

Abstract excerpt

Urothelial neoplasms in patients 19 years of age or younger are rare, and the data regarding clinical outcome are conflicting. Molecular data are not available. Urothelial tumours from 14 patients aged 4 to 19 years were analysed, including FGFR3 and TP53 mutation screening, comparative genomic hybridization (CGH), UroVysion FISH analysis, polymerase chain reaction for human papillomavirus (HPV), microsatellite...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Urinary and Genital Oncology Studies
Share to Urological Disorders and Treatments

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17072825
DOI: 10.1002/path.2075

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic aberrations are rare in urothelial neoplasms of patients 19 years or youngerPMID 17072825Read ↗

[Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome].Semantic proximity Read ↗

Molecular characteristics of urothelial neoplasms in children and young adults: a subset of tumors from young patients harbors chromosomal abnormalities but not FGFR3 or TP53 gene mutations.Semantic proximity Read ↗

Urothelial Carcinoma in Children and Young Adults is Characterized by Higher Frequency of HRAS Mutations and Lower Prevalence of TERT Promoter and FGFR3 Mutations.Semantic proximity Read ↗

Low Frequency of Epigenetic Events in Urothelial Tumors in Young PatientsSemantic proximity Read ↗

H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases.Semantic proximity Read ↗

Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 yearsSemantic proximity Read ↗

The Emerging Molecular Landscape of Urothelial Carcinoma.Semantic proximity Read ↗

[Update on urothelial carcinoma histopathology].Semantic proximity Read ↗

FGFR3 and TP53 mutation analysis in inverted urothelial papilloma: incidence and etiological considerations.Semantic proximity Read ↗

Inverted urothelial papilloma: Diagnostic challenges, molecular insights, and clinical implications.Semantic proximity Read ↗

Frequent FGFR3 mutations in urothelial papillomaSemantic proximity Read ↗

HRAS mutations are frequent in inverted urothelial neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.